학술논문

Three-year Outcomes per PD-L1 Status and Continued Cemiplimab Beyond Progression plus Chemotherapy: EMPOWER-Lung 1
Document Type
Journal
Source
JOURNAL OF THORACIC ONCOLOGY; MAR 2023, 18 3, pE2-pE3, 2p. Supplement: S
Subject
Language
English
ISSN
15561380